688217 睿昂基因
已收盘 03-05 15:00:00
资讯
新帖
简况
睿昂基因发布2025年度业绩快报，亏损0.499亿元
证券之星 · 02-27
睿昂基因发布2025年度业绩快报，亏损0.499亿元
睿昂基因(688217.SH)实控人熊慧、熊钧因涉嫌诈骗罪已被检察机关向法院提起诉讼
智通财经 · 01-23
睿昂基因(688217.SH)实控人熊慧、熊钧因涉嫌诈骗罪已被检察机关向法院提起诉讼
每周股票复盘：睿昂基因（688217）12月26日大宗交易成交940.8万元
证券之星 · 2025-12-28
每周股票复盘：睿昂基因（688217）12月26日大宗交易成交940.8万元
12月26日睿昂基因发生1笔大宗交易 成交金额940.8万元
证券之星 · 2025-12-26
12月26日睿昂基因发生1笔大宗交易 成交金额940.8万元
每周股票复盘：睿昂基因（688217）拟续聘中汇会计为2025审计机构
证券之星 · 2025-11-16
每周股票复盘：睿昂基因（688217）拟续聘中汇会计为2025审计机构
睿昂基因（688217）披露公司2025年第四次临时股东会决议公告，11月14日股价上涨1.26%
证券之星 · 2025-11-14
睿昂基因（688217）披露公司2025年第四次临时股东会决议公告，11月14日股价上涨1.26%
睿昂基因（688217）披露拟续聘中汇会计师事务所为2025年度审计机构，11月11日股价上涨0.51%
证券之星 · 2025-11-11
睿昂基因（688217）披露拟续聘中汇会计师事务所为2025年度审计机构，11月11日股价上涨0.51%
每周股票复盘：睿昂基因（688217）Q3净利降162.56%
证券之星 · 2025-11-02
每周股票复盘：睿昂基因（688217）Q3净利降162.56%
睿昂基因（688217）披露2025年第三季度报告，10月29日股价下跌4.66%
证券之星 · 2025-10-29
睿昂基因（688217）披露2025年第三季度报告，10月29日股价下跌4.66%
图解睿昂基因三季报：第三季度单季净利润同比下降162.56%
证券之星 · 2025-10-28
图解睿昂基因三季报：第三季度单季净利润同比下降162.56%
睿昂基因(688217)9月30日股东户数0.47万户，较上期增加0.62%
证券之星 · 2025-10-28
睿昂基因(688217)9月30日股东户数0.47万户，较上期增加0.62%
每周股票复盘：睿昂基因（688217）拟每10股派1.70元
证券之星 · 2025-10-19
每周股票复盘：睿昂基因（688217）拟每10股派1.70元
睿昂基因（688217）披露2025年半年度权益分派实施公告，10月16日股价下跌1.36%
证券之星 · 2025-10-16
睿昂基因（688217）披露2025年半年度权益分派实施公告，10月16日股价下跌1.36%
每周股票复盘：睿昂基因（688217）完成法定代表人变更
证券之星 · 2025-10-12
每周股票复盘：睿昂基因（688217）完成法定代表人变更
睿昂基因（688217）披露取消监事会并修订《公司章程》议案获通过，10月10日股价下跌0.8%
证券之星 · 2025-10-10
睿昂基因（688217）披露取消监事会并修订《公司章程》议案获通过，10月10日股价下跌0.8%
睿昂基因（688217）披露完成工商变更登记，10月09日股价上涨0.91%
证券之星 · 2025-10-09
睿昂基因（688217）披露完成工商变更登记，10月09日股价上涨0.91%
睿昂基因（688217）披露拟取消监事会并修订公司章程议案，9月29日股价上涨1.15%
证券之星 · 2025-09-29
睿昂基因（688217）披露拟取消监事会并修订公司章程议案，9月29日股价上涨1.15%
每周股票复盘：睿昂基因（688217）现金流改善但营收下滑
证券之星 · 2025-09-21
每周股票复盘：睿昂基因（688217）现金流改善但营收下滑
睿昂基因（688217）发布2025年第二次临时股东大会决议公告，9月17日股价下跌1.16%
证券之星 · 2025-09-17
睿昂基因（688217）发布2025年第二次临时股东大会决议公告，9月17日股价下跌1.16%
每周股票复盘：睿昂基因（688217）拟每10股派1.70元
证券之星 · 2025-09-14
每周股票复盘：睿昂基因（688217）拟每10股派1.70元
加载更多
公司概况
公司名称：
上海睿昂基因科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-05-17
主营业务：
上海睿昂基因科技股份有限公司的主营业务是体外诊断产品的研发、生产、销售及科研、检测服务。公司的主要产品是分子诊断试剂、科研服务、检测服务以及分子检测设备。
发行价格：
18.42
{"stockData":{"symbol":"688217","market":"SH","secType":"STK","nameCN":"睿昂基因","latestPrice":28.48,"timestamp":1772694000000,"preClose":28,"halted":0,"volume":530482,"delay":0,"changeRate":0.0171,"floatShares":55855900,"shares":55855900,"eps":-0.4855,"marketStatus":"已收盘","change":0.48,"latestTime":"03-05 15:00:00","open":28.3,"high":29.08,"low":28.16,"amount":15170100,"amplitude":0.0329,"askPrice":28.49,"askSize":177,"bidPrice":28.48,"bidSize":169,"shortable":0,"etf":0,"ttmEps":-0.4855,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772760600000},"marketStatusCode":5,"adr":0,"adjPreClose":28,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772674200000,1772681400000],[1772686800000,1772694000000]],"highLimit":30.8,"lowLimit":25.2,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":55855896,"isCdr":false,"pbRate":1.76,"roa":"--","roe":"--","epsLYR":-0.28,"committee":-0.134731,"marketValue":1591000000,"turnoverRate":0.0095,"status":0,"afterMarket":{"amount":0,"volume":0,"close":28.48,"buyVolume":0,"sellVolume":0,"time":1772696037558,"indexStatus":"已收盘 03-05 15:30:00","preClose":28},"floatMarketCap":1591000000},"requestUrl":"/m/hq/s/688217","defaultTab":"news","newsList":[{"id":"2614179833","title":"睿昂基因发布2025年度业绩快报，亏损0.499亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614179833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614179833?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:06","pubTimestamp":1772183170,"startTime":"0","endTime":"0","summary":"证券之星消息，睿昂基因近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润亏损0.499亿元，同比减少216.43%。睿昂基因主营业务：体外诊断产品的研发、生产、销售及科研、检测服务,主要为血液病、实体瘤和传染病患者提供基因及抗原的精准检测,为疾病诊断、风险评估、疾病分型、靶向药物选择和疗效监测等个体化治疗方案的制定提供依据。该股最近90天内无机构评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700027559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2605408625","title":"睿昂基因(688217.SH)实控人熊慧、熊钧因涉嫌诈骗罪已被检察机关向法院提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2605408625","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605408625?lang=zh_cn&edition=full","pubTime":"2026-01-23 21:21","pubTimestamp":1769174510,"startTime":"0","endTime":"0","summary":"智通财经APP讯，睿昂基因(688217.SH)发布公告，前期，公司实际控制人熊慧女士、熊钧先生因涉嫌诈骗罪已被批捕。近日，公司收到实际控制人熊慧女士、熊钧先生家属的通知，实际控制人熊慧女士、熊钧先生因涉嫌诈骗罪已被检察机关向法院提起诉讼。熊慧女士、熊钧先生目前未在公司担任董事或高级管理人员职务，上述事项不会对公司日常经营活动产生重大不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"睿昂基因(688217.SH)实控人熊慧、熊钧因涉嫌诈骗罪已被检察机关向法院提起诉讼","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2594247323","title":"每周股票复盘：睿昂基因（688217）12月26日大宗交易成交940.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247323","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247323?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:57","pubTimestamp":1766869027,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，睿昂基因（688217）报收于26.12元，较上周的26.65元下跌1.99%。本周，睿昂基因12月22日盘中最高价报26.88元。12月23日盘中最低价报25.87元。睿昂基因当前最新总市值14.59亿元，在医疗器械板块市值排名127/127，在两市A股市值排名5158/5178。本周关注点交易信息汇总：12月26日睿昂基因发生1笔大宗交易，成交金额940.8万元交易信息汇总12月26日睿昂基因发生1笔大宗交易，成交金额940.8万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2594298397","title":"12月26日睿昂基因发生1笔大宗交易 成交金额940.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594298397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594298397?lang=zh_cn&edition=full","pubTime":"2025-12-26 17:49","pubTimestamp":1766742555,"startTime":"0","endTime":"0","summary":"证券之星消息，12月26日睿昂基因发生大宗交易，交易数据如下：大宗交易成交价格23.52元，相对当日收盘价折价9.95%，成交40万股，成交金额940.8万元，买方营业部为国元证券股份有限公司深圳益田路证券营业部，卖方营业部为东海证券股份有限公司深圳深南大道证券营业部。近三个月该股共发生1笔大宗交易，合计成交4000.0手，折价成交1笔。截至2025年12月26日收盘，睿昂基因报收于26.12元，下跌1.36%，换手率1.14%，成交量6354.0手，成交额1677.9万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600026010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2583465446","title":"每周股票复盘：睿昂基因（688217）拟续聘中汇会计为2025审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2583465446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583465446?lang=zh_cn&edition=full","pubTime":"2025-11-16 05:00","pubTimestamp":1763240434,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，睿昂基因报收于29.84元，较上周的28.72元上涨3.9%。本周，睿昂基因11月14日盘中最高价报30.29元。本周关注点公司公告汇总：睿昂基因拟续聘中汇会计师事务所为2025年度审计机构，审计费用合计100万元（不含税），与2024年度持平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2583507684","title":"睿昂基因（688217）披露公司2025年第四次临时股东会决议公告，11月14日股价上涨1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583507684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583507684?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:02","pubTimestamp":1763132548,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，睿昂基因报收于29.84元，较前一交易日上涨1.26%，最新总市值为16.67亿元。该股当日开盘29.39元，最高30.29元，最低29.11元，成交额达2645.58万元，换手率为1.58%。近日，上海睿昂基因科技股份有限公司发布2025年第四次临时股东会决议公告。公告显示，公司于2025年11月14日召开2025年第四次临时股东会，会议由董事会召集，董事长主持，采用现场与网络投票结合方式举行。出席会议股东共26人，代表表决权股份7,156,599股，占公司总表决权比例12.9681%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400042374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2582360371","title":"睿昂基因（688217）披露拟续聘中汇会计师事务所为2025年度审计机构，11月11日股价上涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582360371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582360371?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:53","pubTimestamp":1762872797,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，睿昂基因报收于29.29元，较前一交易日上涨0.51%，最新总市值为16.36亿元。该股当日开盘29.37元，最高29.42元，最低29.01元，成交额达1610.41万元，换手率为0.99%。根据近日发布的2025年第四次临时股东会会议资料，上海睿昂基因科技股份有限公司拟续聘中汇会计师事务所为2025年度审计机构，负责财务报告和内部控制审计工作。该议案已由第三届董事会第七次会议审议通过，现提请股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100041341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2580405699","title":"每周股票复盘：睿昂基因（688217）Q3净利降162.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580405699","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580405699?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:15","pubTimestamp":1762049716,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，睿昂基因报收于29.2元，较上周的28.81元上涨1.35%。本周，睿昂基因10月28日盘中最高价报29.64元。本周关注点业绩披露要点：睿昂基因2025年第三季度归母净利润-917.5万元，同比下降162.56%。股本股东变化截至2025年9月30日，睿昂基因股东户数为4715户，较6月30日增加29户，增幅0.62%。公司公告汇总睿昂基因披露2025年第三季度报告，未经审计数据显示，公司前三季度营收1.39亿元，归母净利润-562.07万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2579129976","title":"睿昂基因（688217）披露2025年第三季度报告，10月29日股价下跌4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579129976","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579129976?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:19","pubTimestamp":1761733157,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，睿昂基因报收于28.22元，较前一交易日下跌4.66%，最新总市值为15.76亿元。近日，睿昂基因发布2025年第三季度报告。公告显示，公司2025年前三季度实现营业收入139,103,619.10元，同比下降26.64%；归属于上市公司股东的净利润为-5,620,662.24元，同比下降198.14%。报告期末普通股股东总数为4,715户。在主要财务指标方面，2025年前三季度经营活动产生的现金流量净额为26,861,231.93元，同比下降17.60%；基本每股收益为-0.10元，同比下降200.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900038897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2578930842","title":"图解睿昂基因三季报：第三季度单季净利润同比下降162.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578930842","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578930842?lang=zh_cn&edition=full","pubTime":"2025-10-28 18:48","pubTimestamp":1761648482,"startTime":"0","endTime":"0","summary":"证券之星消息，睿昂基因2025年三季报显示，公司主营收入1.39亿元，同比下降26.64%；归母净利润-562.07万元，同比下降198.14%；扣非净利润-1219.8万元，同比下降1107.18%；其中2025年第三季度，公司单季度主营收入3435.53万元，同比下降37.35%；单季度归母净利润-917.5万元，同比下降162.56%；单季度扣非净利润-937.05万元，同比下降138.33%；负债率4.17%，投资收益170.99万元，财务费用-120.98万元，毛利率73.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800035143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688217"],"gpt_icon":0},{"id":"2578936948","title":"睿昂基因(688217)9月30日股东户数0.47万户，较上期增加0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578936948","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578936948?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:23","pubTimestamp":1761643428,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿昂基因披露，截至2025年9月30日公司股东户数为4715.0户，较6月30日增加29.0户，增幅为0.62%。在医疗器械行业个股中，睿昂基因股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，睿昂基因区间涨幅为12.92%，在此期间股东户数增加29.0户，增幅为0.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2576044072","title":"每周股票复盘：睿昂基因（688217）拟每10股派1.70元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576044072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576044072?lang=zh_cn&edition=full","pubTime":"2025-10-19 05:30","pubTimestamp":1760823028,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，睿昂基因报收于27.36元，较上周的28.6元下跌4.34%。本周，睿昂基因10月14日盘中最高价报28.78元。截至公告日，公司总股本55,855,896股，扣减回购股份669,621股，实际参与分配股本55,186,275股，合计拟派发现金红利9,381,666.75元（含税）。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2575740206","title":"睿昂基因（688217）披露2025年半年度权益分派实施公告，10月16日股价下跌1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575740206","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575740206?lang=zh_cn&edition=full","pubTime":"2025-10-16 22:43","pubTimestamp":1760625790,"startTime":"0","endTime":"0","summary":"截至2025年10月16日收盘，睿昂基因报收于27.6元，较前一交易日下跌1.36%，最新总市值为15.42亿元。该股当日开盘28.14元，最高28.15元，最低27.43元，成交额达2068.01万元，换手率为1.33%。近日，睿昂基因发布《2025年半年度权益分派实施公告》。根据公告，本次利润分配方案已经公司2025年9月16日召开的第二次临时股东大会审议通过。股权登记日为2025年10月23日，除权（息）日为2025年10月24日，现金红利发放日为2025年10月24日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600037341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2574463357","title":"每周股票复盘：睿昂基因（688217）完成法定代表人变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2574463357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574463357?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:44","pubTimestamp":1760211850,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，睿昂基因报收于28.6元，较上周的28.57元上涨0.11%。本周，睿昂基因10月9日盘中最高价报29.87元。本周关注点公司公告汇总：睿昂基因完成法定代表人变更，董事长高尚先兼任总经理并出任法定代表人。公司公告汇总：睿昂基因股东大会审议通过取消监事会及修订公司章程议案，获99.0623%同意。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2574170195","title":"睿昂基因（688217）披露取消监事会并修订《公司章程》议案获通过，10月10日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574170195","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574170195?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:56","pubTimestamp":1760108176,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，睿昂基因报收于28.6元，较前一交易日下跌0.8%，最新总市值为15.97亿元。近日，睿昂基因发布2025年第三次临时股东大会决议公告。公告显示，公司于2025年10月10日召开2025年第三次临时股东大会，会议审议通过了《关于取消监事会并修订<公司章程>的议案》及多项内部制度修订议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2574494130","title":"睿昂基因（688217）披露完成工商变更登记，10月09日股价上涨0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574494130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574494130?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:42","pubTimestamp":1760002961,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，睿昂基因报收于28.83元，较前一交易日上涨0.91%，最新总市值为16.1亿元。该股当日开盘28.82元，最高29.87元，最低28.75元，成交额达5025.38万元，换手率为3.06%。公司近日发布公告称，已完成工商变更登记并取得上海市市场监督管理局换发的《营业执照》。上述事项已在相关主管部门完成登记备案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900023629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2571386151","title":"睿昂基因（688217）披露拟取消监事会并修订公司章程议案，9月29日股价上涨1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571386151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571386151?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:33","pubTimestamp":1759138401,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，睿昂基因报收于28.03元，较前一交易日上涨1.15%，最新总市值为15.66亿元。该股当日开盘27.84元，最高28.1元，最低27.14元，成交额达2287.74万元，换手率为1.48%。近日，睿昂基因发布2025年第三次临时股东大会会议资料，宣布公司将于2025年10月10日召开第三次临时股东大会。相关公告已于2025年9月24日在上海证券交易所网站披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900023832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2569493562","title":"每周股票复盘：睿昂基因（688217）现金流改善但营收下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2569493562","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569493562?lang=zh_cn&edition=full","pubTime":"2025-09-21 05:06","pubTimestamp":1758402377,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，睿昂基因报收于27.7元，较上周的28.51元下跌2.84%。本周，睿昂基因9月17日盘中最高价报28.74元。公司公告汇总上海市锦天城律师事务所对上海睿昂基因科技股份有限公司2025年第二次临时股东大会出具法律意见书。本次股东大会由公司董事会召集，于2025年9月16日以现场和网络投票方式召开，会议召集程序合法。出席本次股东大会的股东及代理人共33人，代表有表决权股份17,398,504股，占公司有表决权股份总数的31.5269%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159399","688217"],"gpt_icon":0},{"id":"2568642904","title":"睿昂基因（688217）发布2025年第二次临时股东大会决议公告，9月17日股价下跌1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568642904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568642904?lang=zh_cn&edition=full","pubTime":"2025-09-17 17:31","pubTimestamp":1758101469,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，睿昂基因报收于28.22元，较前一交易日下跌1.16%，最新总市值为15.76亿元。公司于近日披露了《睿昂基因2025年第二次临时股东大会决议公告》。公告显示，上海睿昂基因科技股份有限公司于2025年9月16日召开2025年第二次临时股东大会，会议由董事会召集，董事长高尚先主持，采用现场与网络投票结合方式举行。出席会议的股东及代理人共33人，代表有表决权股份17,398,504股，占公司有表决权股份总数的31.5269%。本次会议无被否决议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700030445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2567136978","title":"每周股票复盘：睿昂基因（688217）拟每10股派1.70元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136978","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567136978?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:54","pubTimestamp":1757796849,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，睿昂基因报收于28.51元，较上周的28.74元下跌0.8%。本周，睿昂基因9月8日盘中最高价报30.08元。公司公告汇总：睿昂基因拟向全体股东每10股派发现金红利1.70元（含税）。睿昂基因拟实施2025年半年度利润分配方案。公司拟向全体股东每10股派发现金红利1.70元（含税），总股本55,855,896股，扣减回购专用账户股份669,621股后，实际参与分派股份为55,186,275股，拟派发现金红利总额9,381,666.75元（含税），占2025年半年度归属于母公司所有者净利润的263.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688217","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772748359911,"stockEarnings":[{"period":"1week","weight":-0.0842},{"period":"1month","weight":-0.0619},{"period":"3month","weight":0.0615},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.2483},{"period":"ytd","weight":0.0808}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.2294},{"period":"ytd","weight":0.0352}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海睿昂基因科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4715人(较上一季度增加0.62%)","perCapita":"11846股","listingDate":"2021-05-17","address":"上海市奉贤区金海公路6055号3幢","registeredCapital":"5585万元","survey":" 上海睿昂基因科技股份有限公司的主营业务是体外诊断产品的研发、生产、销售及科研、检测服务。公司的主要产品是分子诊断试剂、科研服务、检测服务以及分子检测设备。","listedPrice":18.42},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿昂基因(688217)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿昂基因(688217)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿昂基因,688217,睿昂基因股票,睿昂基因股票老虎,睿昂基因股票老虎国际,睿昂基因行情,睿昂基因股票行情,睿昂基因股价,睿昂基因股市,睿昂基因股票价格,睿昂基因股票交易,睿昂基因股票购买,睿昂基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿昂基因(688217)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿昂基因(688217)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}